By Manas Mishra and Julie Steenhuysen
April 23 (Reuters) - Use of Johnson & Johnson s COVID-19 vaccine should resume in the United States, advisers to U.S. health regulators said on Friday, after reviewing data showing it will help save lives and prevent hospitalizations despite the risk of extremely rare but potentially deadly blood clots.
The recommendation paves the way for J&J s one-dose shot to begin going into arms again in the United States, once they are confirmed by regulators.
The U.S. Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration paused its use last week in order to review reports of the dangerous blood clot condition accompanied by low blood platelets.
US Ends Pause On Johnson & Johnson Vaccine, Says More Benefits Than Risks
ndtv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ndtv.com Daily Mail and Mail on Sunday newspapers.
US lifts pause on Johnson & Johnson vaccine after advisers say benefits outweigh risk
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
US health agencies lift pause on use of Johnson & Johnson Covid-19 vaccine Health systems and vaccine recipients to be warned of risk of syndrome involving blood clots, say FDA and CDC
about 5 hours ago Updated: about 3 hours ago
Bottles of the single-dose Johnson & Johnson Janssen Covid-19 vaccine. Photograph: Jorge Guerrero/AFP
The United States will resume use of Johnson & Johnson s Covid-19 vaccine, top health regulators said on Friday, ending a 10-day pause to investigate the vaccine s link to extremely rare but potentially deadly blood clots.
The US Centers for Disease Control and Prevention (CDC) and the US Food and Drug Administration (FDA) said in a joint statement that health systems and vaccine recipients would be warned of the risk of a potentially fatal syndrome involving severe blood clots and low platelets.